Association between dermatological diseases and pathological changes in the gastrointestinal tract

Postepy Dermatologii i Alergologii

Volumn 28, Issue 6, 2011, Pages 506-513

  Chmiel, Katarzyna ^a   Krela Kaźmierczak, Iwona ^a   Łykowska Szuber, Liliana ^a   Niśkiewicz, Izabela ^a   Linke, Krzysztof ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Dermatitis herpetiformis; Erythema nodosum; Gardner syndrome; Mastocytosis; Paraneoplastic syndromes; Peutz Jeghers syndrome; Systemic scleroderma

Indexed keywords

CONNECTIVE TISSUE GROWTH FACTOR; EPIDERMAL GROWTH FACTOR; GLUTEN; HLA A1 ANTIGEN; HLA B8 ANTIGEN; HLA DQ2 ANTIGEN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE LKB1; PROTEIN SERINE THREONINE KINASE; SOMATOMEDIN; TRANSFORMING GROWTH FACTOR BETA;

ACANTHOSIS NIGRICANS; ALCOHOL INTOLERANCE; CELIAC DISEASE; CELL DIFFERENTIATION; CHROMOSOME 19P; CLINICAL FEATURE; CONSTIPATION; CRONKHITE CANADA SYNDROME; DERMATITIS HERPETIFORMIS; DIARRHEA; DIGESTIVE SYSTEM CANCER; DISEASE ASSOCIATION; EHLERS DANLOS SYNDROME; ENTERITIS; EPIDERMOLYSIS BULLOSA; EPIDERMOLYSIS BULLOSA SIMPLEX; ERYTHEMA NODOSUM; ESOPHAGUS VARICES; GARDNER SYNDROME; GASTROINTESTINAL DISEASE; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL SYMPTOM; HEPATOMEGALY; HLA SYSTEM; HUMAN; HYPERPIGMENTATION; KERATINOCYTE; MASTOCYTOSIS; MELANOMA; METASTASIS; PARANEOPLASTIC SYNDROME; PEPTIC ULCER; PEUTZ JEGHERS SYNDROME; PYODERMA GANGRENOSUM; REVIEW; SKIN DISEASE; SYSTEMIC SCLEROSIS; TELANGIECTASIA; ZOLLINGER ELLISON SYNDROME;

EID: 84855163260     PISSN: 1642395X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (40)

1. Rassner G, Steinert U. Dermatologia Podrȩcznik i atlas. Urban & Partner, Wrocław, 2004 [in Polish].
2. Jabłońska S, Majewski S. Choroby skóry i choroby przenoszone droga̧ płciowa̧. PZWL, Warszawa 2005 [in Polish].
3. Serin G, Doǧanavşargil B, Çalişkan C. Colonic malignant melanoma, primary or metastatic? Case report. Turk J Gastroenterol 2010; 21: 45-9.
4. Manouras A, Genetzakis M, Lagoudianaki E. Malignant gastrointestinal melanomas of unknown origin: should it be considered primary? World J Gastroenterol 2007; 13: 4027-9. (Pubitemid 47272507)
5. Niedoszytko M, Gruchała-Niedoszytko M. Mastocytoza-patogeneza, rozpoznanie, leczenie. Alergia Astma Immunol 2005; 10: 181-6.
6. Lee JK, Whittaker SJ, Enns RA. Gastrointestinal manifestations of systemic masocytosis. World J Gastroenterol 2008; 14: 7005-8.
7. Wielosz E, Borys O, Żychowska I. Gastrointestinal involvement in patients with systemic sclerosis. Pol Arch Med Wewn 2010; 120: 132-5.
8. Kawaguchi Y, Nakamura Y, Matsumoto I. Muscarinic-3 acetylcholine receptor autoantibody in patients with systemie sclerosis: contibution to severe gastrointestinal tract dysmotility. Ann Rheum Dis 2009; 68: 710-4.
9. Fine JD, Johnson LB, Weiner M. Gastrointestinal complications of inherited epidermolysis bullosa: cumulative experience of the National Epidermolysis Bullosa Registry. J Paediatr Gastroenterol Nutr 2008; 46: 147-58. (Pubitemid 351161120)
10. Jabbar AS. Ehlers-Danlos syndrome type IV associated with arterial and bowel perforation. Ann Saudi Med 2000; 20: 421-3. (Pubitemid 32851348)
11. Trost L, McDonnel JK. Important cutaneous manifestations of inflammatory bowel disease. Postgrad Med J 2005; 81: 580-5. (Pubitemid 41297914)
12. Yüksel I.L, Başar O{combining double acute accent}, Ataseven H. Mucocutaneous manifestations in inflammatory bowel disease. Inflamm Bowel Dis 2009; 15: 546-50.
13. Freedeberg IM, Eizen AZ, Wolff K. Fitzpatrick's dermatology in general medicine. McGraw-Hill, New York 2003.
14. Branagan NM, Higgins SP, Halim SA, LeTH. Systemic polyartheritis nodosa mimicking pyoderma gangrenosum in a rare assosciation with small lymphocytic leukaemia/chronic lymphocytic leukaemia Clin Exp Dermatol 2009; 34: 127-9.
15. Brooklyn T, Dunnil G, Probert O. Diagnosis and treatment of pyoderma gangrenosum. Br Med J 2006; 333: 181-4. (Pubitemid 44406745)
16. Humbert P, Pelletier F, Dreno B. Gluten intolerance and skin diseases. Eur J Dermatol 2006; 16: 4-11. (Pubitemid 43219398)
17. Reunala TL. Dermatitis herpetiformis. Clin Dermatol 2001; 19: 728-36. (Pubitemid 33035022)
18. Cronkhite LW Jr, Canada WJ. General gastrointestinal polyposis an unusual syndrome of polyposis, pigmentation, alopecia, and onychodystrophia. N Engl J Med 1955; 252: 1011-5.
19. Goto A. Cronkhite Canada syndrome: epidemiological study of 110 cases reported in Japan. Nippon Geka Hokan, 1995; 64: 3-14.
20. Krawczyk M, Mykala-Ciesla J, Kolodziej-Jaskula A. Acanthosis nigricans as a paraneoplastic syndrome. Case reports and review of literature. Pol Arch Med Wewn 2009; 119: 180-3.
21. Scott AT, Metzig AM, Hames RK, et al. Acanthosis nigricans and oral glucose tolerance in obese children. Clin Pediatr (Phila) 2010; 49: 69-71.
22. Nair P, Moorthy P, Supracasan S, et al. Malignant acanthosis nigricans with liver secondaries from an occult primary adenocarcinoma of gastrointestinal tract. Indian J Dermatol 2005; 71: 197.
23. Pertenero M, Carazzo M, Pagano M, et al. Oral acanthosis nigricans, tripe palms and sign of Leser-Trelat in a patient with gastric adenocarcinoma. Int J Dermatol 2004; 43: 530-2. (Pubitemid 39023043)
24. Möhrenschlager M, Vocks E, Wessner DB, et al. Tripe palms and malignant acanthosis nigricans: cutaneous signs of imminent metastasis in bladder cancer? J Urol 2001; 1629-30. (Pubitemid 32410265)
25. Ponti G, Luppi G, Losi L, et al. Leser-Trélat syndrome in patients affected by six multiple metachronous primitive cancers. J Hematol Oncol 2010; 3: 2.
26. Ellis DL, Yates RA. Sign of leser-trelat. Clin Dermatol 1993; 11: 141-8. (Pubitemid 23191680)
27. Singhi MK, Gupta LK, Bansal M, et al. Florid cutaneous papillomatosis with adenocarcinoma of stomach in a 35 year old male. Indian J Dermatol Venereol Leprol 2005; 71: 195-6. (Pubitemid 40898207)
28. Lorette G, Maruani A. Acquired hypertrichosis lanuginosa. N Engl J Med 2006; 6: 354.
29. Louvel G, Vauleon E, Boucher E. Acrokeratosis paraneoplastica (Bazex syndrome) associated with metastatic squamous cell esophageal carcinoma. J Clin Oncol 2008; 26: 5128-9.
30. Giardiello FM, Trimbath JD. Peutz-Jeghers syndrome and management recommendations. Clin Gastroenterol Hepatol 2006; 4: 408-15.
31. Utsunomiya J, Gocho H, Miyanaga T, et al. Peutz-Jeghers syndrome: its natural course and management. Johns Hopkins Med J 1975; 136: 71-82.
32. De Leng WW, Jansen M, Carvalho R. Genetic defects underlying Peutz-Jeghers syndrome (PJS) and exclusion of the polarity- associated MARK/Par1 gene family as potential PJS candidates. Clin Genet 2007; 72: 568-73. (Pubitemid 350131065)
33. Mehenni H, Resta N, Guanti G, et al. Molecular and clinical characteristics in 46 families affected with Peutz-Jeghers syndrome. Dig Dis Sci 2007; 52: 1924-33. (Pubitemid 47024661)
34. Giardiello FM, Brensinger JD, Tersmette AC. Very high risk of cancer in familial Peutz-Jeghers syndrome. Gastroenterology 2000; 119: 1447-53. (Pubitemid 32198669)
35. Blumenthal GM, Dennis PA. PTEN hamartoma tumor syndromes. Eur J Hum Genet 2008; 16: 1289-300.
36. Schaffer JV, Kamino H, Witkiewicz A, et al. Mucocutaneous neuromas: an underrecognized manifestation of PTEN hamartoma-tumor syndrome. Arch Dermatol 2006; 142: 625-32. (Pubitemid 43727554)
37. Guo-Li G, Shi-Lin W, Xue-Ming W. Diagnosis and treatment of Gardner syndrome with gastric polyposis: a case report and review of the literature. World J Gastroenterol 2008; 14: 2121-3.
38. Ascari-Raccagni A, Baldari U, Righini MG. Cutaneous symptoms of Gardner's syndrome. J Eur Acad Dermatol Venereol 1999; 12: 80-1.
39. Dores GM, Curtis RE, Toro JR, et al. Incidence of cutaneous sebaceous carcinoma and risk of associated neoplasms: insight into Muir-Torre syndrome. Cancer 2008; 113: 3372-81.
40. Lipton LR, Johnson V, Cummings C. Refining the Amsterdam criteria and Bethesda Guidelines: testing algorithms for the prediction of mismatch repair mutation status in the familial cancer clinic. J Clin Oncol 2004; 22: 4934-43. (Pubitemid 46638618)